Cite
Optimized Inhibition of GM-CSF in Preclinical Models of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy
MLA
Erin E. Tapper, et al. “Optimized Inhibition of GM-CSF in Preclinical Models of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy.” Blood, vol. 138, Nov. 2021, p. 2777. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b2a974e2c15452e55b1c4de27b4f4f7a&authtype=sso&custid=ns315887.
APA
Erin E. Tapper, Cameron Durrant, Reona Sakemura, Ekene J. Ogbodo, Neil E. Kay, Lionel A. Kankeu Fonkoua, Michael W. Ruff, Gunjan A Awatramani, Susan L. Slager, Michelle J. Cox, Elizabeth L. Siegler, Ismail Can, Sameer A. Parikh, James Girsch, Kendall J. Schick, Omar J. Ahmed, Carli M. Stewart, Evandro D. Bezerra, Mehrdad Hefazi, … Dale Chappell. (2021). Optimized Inhibition of GM-CSF in Preclinical Models of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy. Blood, 138, 2777.
Chicago
Erin E. Tapper, Cameron Durrant, Reona Sakemura, Ekene J. Ogbodo, Neil E. Kay, Lionel A. Kankeu Fonkoua, Michael W. Ruff, et al. 2021. “Optimized Inhibition of GM-CSF in Preclinical Models of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy.” Blood 138 (November): 2777. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b2a974e2c15452e55b1c4de27b4f4f7a&authtype=sso&custid=ns315887.